HomeCompareIPLDP vs MRK

IPLDP vs MRK: Dividend Comparison 2026

IPLDP yields 44.62% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPLDP wins by $37622020424.15M in total portfolio value
10 years
IPLDP
IPLDP
● Live price
44.62%
Share price
$24.99
Annual div
$11.15
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37622020424.21M
Annual income
$37,460,745,562,858,744.00
Full IPLDP calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — IPLDP vs MRK

📍 IPLDP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPLDPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPLDP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IPLDP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPLDP
Annual income on $10K today (after 15% tax)
$3,792.86/yr
After 10yr DRIP, annual income (after tax)
$31,841,633,728,429,932.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, IPLDP beats the other by $31,841,633,728,421,336.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPLDP + MRK for your $10,000?

IPLDP: 50%MRK: 50%
100% MRK50/50100% IPLDP
Portfolio after 10yr
$18811010212.13M
Annual income
$18,730,372,781,434,428.00/yr
Blended yield
99.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IPLDP
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPLDP buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPLDPMRK
Forward yield44.62%2.81%
Annual dividend / share$11.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$37622020424.21M$57.7K
Annual income after 10y$37,460,745,562,858,744.00$10,113.78
Total dividends collected$37611389898.79M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IPLDP vs MRK ($10,000, DRIP)

YearIPLDP PortfolioIPLDP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,624$8,924.37$11,213$373.04+$8.4KIPLDP
2$53,734$32,735.54$12,667$512.06+$41.1KIPLDP
3$225,034$167,539.05$14,439$708.14+$210.6KIPLDP
4$1,552,275$1,311,488.18$16,640$988.16+$1.54MIPLDP
5$18,570,442$16,909,507.98$19,432$1,394.07+$18.55MIPLDP
6$397,991,445$378,121,072.02$23,057$1,992.90+$397.97MIPLDP
7$15,572,919,705$15,147,068,859.28$27,889$2,894.79+$15572.89MIPLDP
8$1,124,487,932,327$1,107,824,908,242.75$34,518$4,286.29+$1124487.90MIPLDP
9$150,724,169,486,296$149,520,967,398,705.66$43,912$6,494.35+$150724169.44MIPLDP
10$37,622,020,424,209,080$37,460,745,562,858,744.00$57,714$10,113.78+$37622020424.15MIPLDP

IPLDP vs MRK: Complete Analysis 2026

IPLDPStock

Interstate Power and Light Company, a public utility company, generates and distributes electricity, and distributes and transports natural gas to retail customers in Iowa. The company operates through three segments: Electric Operations, Gas Operations, and Other. It generates electricity from coal, natural gas, and wind energy; and purchases electricity from wholesale energy markets. The company also sells electricity to wholesale customers, including municipalities and rural electric cooperatives in Minnesota, Illinois, and Iowa. In addition, it generates and distributes steam for customers in Cedar Rapids, Iowa; and owns overhead electric distribution lines, underground electric distribution cables, and substation distribution transformers, as well as gas mains in Iowa. The company provides utility services to incorporated communities. It offers electric utility services to retail customers in various industries, such as farming, agriculture, industrial manufacturing, chemical, packaging, and food industries, as well as gas utility services for various industries comprising research, education, hospitality, manufacturing, and chemicals. As of December 31, 2020, it supplied electric service to approximately 495,000 retail customers and natural gas service to approximately 225,000 retail customers. The company was formerly known as Iowa Railway and Light Corporation. The company was incorporated in 1925 and is based in Cedar Rapids, Iowa. Interstate Power and Light Company operates as a subsidiary of Alliant Energy Corporation.

Full IPLDP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IPLDP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPLDP vs SCHDIPLDP vs JEPIIPLDP vs OIPLDP vs KOIPLDP vs MAINIPLDP vs JNJIPLDP vs ABBVIPLDP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.